Fig. 4From: Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysisRisk of HBVr between HBsAg positive patients and HBsAg negative patients. HBVr hepatitis B virus reactivation, HBsAg hepatitis B surface antigen, ES effect size, CI: confidence intervalBack to article page